Management of Aortopathies in Bicuspid Aortic Valve Patients
Patients with bicuspid aortic valve (BAV) require lifelong surveillance and specific management of associated aortopathy, with surgical intervention recommended when aortic diameter reaches ≥55 mm in most cases, or ≥50 mm with additional risk factors. 1
Diagnostic Approach
Initial Evaluation
- Transthoracic echocardiography (TTE) is the primary imaging modality for initial assessment of BAV and aortic dimensions 1
- Cardiac MRI or CT is indicated when:
Family Screening
- Screening of first-degree relatives (parents, siblings, children) of BAV patients is recommended, especially those with root phenotype aortopathy 1, 2
- Family screening has been shown to be cost-effective, with 9-20% of relatives having BAV 1
Surveillance Protocol
For BAV Patients with Aortic Dilation
For aortic diameter >45 mm or growth rate >3 mm/year:
For aortic diameter >40 mm:
For patients with previous AVR and aortic diameter ≥4.0 cm:
Surgical Management
Primary Indications for Aortic Replacement
Strong recommendation for surgery (Class I):
Reasonable to consider surgery (Class IIa):
- Aortic diameter 50-55 mm with additional risk factors 1:
- Family history of aortic dissection
- Aortic growth rate >3 mm per year (or >0.5 cm per year)
- Aortic coarctation
- Systemic hypertension
- Age <50 years
- Short stature
- Ascending aortic length ≥11 cm
- Resistant hypertension
- Desire for pregnancy
- Aortic diameter 50-55 mm with additional risk factors 1:
May consider surgery (Class IIb):
Medical Management
- Optimal blood pressure control targeting <140/90 mmHg 2
- Beta-blockers are preferred first-line agents for blood pressure control 2
- Regular moderate aerobic exercise is recommended 2
- Avoidance of strenuous isometric exercise, contact sports, and competitive sports (especially with borderline aortic diameters) 2
Special Considerations
Post-Surgical Follow-up
- Continued lifelong surveillance is essential even after aortic valve replacement 1
- Progressive aortic enlargement occurs in approximately 10% of patients after isolated AVR 1
- Subsequent aortic dissection occurs in about 1% of patients after isolated AVR 1
Risk Stratification
- Root phenotype and predominant aortic regurgitation are associated with greater risk of aortic growth and complications 1
- Patients with BAV who underwent AVR for aortic regurgitation have higher risk for late aortic events than those who underwent AVR for aortic stenosis 1
Common Pitfalls and Caveats
Measurement consistency: Use the same imaging modality for serial measurements to ensure accurate comparison 2
Continued surveillance after valve surgery: The aorta may continue to dilate even after isolated AVR 1
Phenotype matters: Root phenotype and aortic regurgitation are associated with higher risk of aortic complications 1
Comprehensive assessment: Evaluate the entire thoracic aorta, not just the ascending portion, as BAV aortopathy can affect multiple segments 1
Surgical expertise: Complex aortic surgeries should be performed at Comprehensive Valve Centers with experienced surgeons 1